CAPG and Miyoshi myopathy: Additional consideration of the comparison of Meso 163 versus Meso 34 human MM cell lines revealed that CAPG was the only biomarker exhibiting similar changes (a strong tendency was also observed for LAMB2), while there were no significant changes for FABP4 (Table 1 and Figure 3).